4.7 Review

Synthetic 3D multicellular systems for drug development

Journal

CURRENT OPINION IN BIOTECHNOLOGY
Volume 23, Issue 5, Pages 803-809

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2012.01.011

Keywords

-

Funding

  1. Gebert-Ruf Foundation, Switzerland [GRS-040/10]

Ask authors/readers for more resources

Since the 1970s, the limitations of two dimensional (2D) cell culture and the relevance of appropriate three dimensional (3D) cell systems have become increasingly evident. Extensive effort has thus been made to move cells from a flat world to a 3D environment. While 3D cell culture technologies are meanwhile widely used in academia, 2D culture technologies are still entrenched in the (pharmaceutical) industry for most kind of cell-based efficacy and toxicology tests. However, 3D cell culture technologies will certainly become more applicable if biological relevance, reproducibility and high throughput can be assured at acceptable costs. Most recent innovations and developments clearly indicate that the transition from 2D to 3D cell culture for industrial purposes, for example, drug development is simply a question of time.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available